Editor of Patient Care Online.
Clinician Education on Obesity Has Not Caught Up to Disease State, Says OMA President
Angela Fitch, MD, discusses the importance of clinician education in addressing obesity with patients.
Addressing the Gap: Advocacy Groups Call for Inclusion of Patients with Obesity in Clinical Trials
President of the Obesity Medicine Association discusses a recent joint statement from the OMA and 4 other organizations calling for inclusion of patients with obesity in drug research.
Daily Dose: Impact of COVID-19 Pandemic on Parental Vaccine Hesitancy in the US
Your daily dose of the clinical news you may have missed.
Daily Dose: USPSTF Recommends Behavioral Interventions for Children with Obesity
Daily Dose: Pregnancy-related ESKD Influences Access to Nephrology Care
Daily Dose: Treating the Gut Microbiome Shortens Long COVID
Key Developments in Obesity Medicine in 2023: An Expert Discussion
Angela Fitch, MD, president of the Obesity Medicine Association discusses key pharmaceutical and research developments in obesity medicine in 2023.
Daily Dose: Tirzepatide Discontinuation Results in Weight Regain
FDA Updates LDL-C Lowering Indication for Bempedoic Acid, Bempedoic Acid plus Ezetimibe Tablets
The US FDA approved expanded indications for bempedoic acid and bempedoic acid plus ezetimibe for primary hyperlipidemia.
Daily Dose: Omega-3 Fatty Acids Reduce CVD Risk in Individuals with Family History of CVD
Daily Dose: Nerivio Neuromodulation Device for Migraine
USPSTF Recommends Intensive, Behavioral Interventions for Children and Adolescents with Obesity
The task force recommends clinicians provide or refer children and adolescents with a high BMI to intensive, comprehensive behavioral interventions.
Daily Dose: Vegan Diet Linked to Better Cardiovascular Health
Tirzepatide Demonstrates Sustained Weight Loss but Discontinuation Results in Weight Regain: SURMOUNT-4 Trial
Study participants randomized to placebo for 1 year after 36 weeks on tirzepatide had mean weight regain of 14% vs augmented loss among those who continued on the medication.
Daily Dose: Eligible Adults Lack Statin Prevention for ASCVD
New Data Show Omega-3 Polyunsaturated Fatty Acids Lower CVD Risk in Persons with Family History of CVD
Higher intake of omega-3 polyunsaturated fatty acids may reduce the risk for cardiovascular disease in persons with a family history of CVD.
Daily Dose: Coadministration of RSV and Influenza Vaccines
High Prevalence of Husband, Wife Duos with Hypertension Observed Globally in New Study
The prevalence of concordant hypertension among middle-aged and older heterosexual couples in the US, UK, China, and India ranged from 20% go 47%, reported researchers.
Daily Dose: Extended Use of ADHD Drugs Linked to Higher CVD Risk
Vegan Diet Linked to Better Cardiovascular Health in New Study of Identical Twins
Twins randomly assigned to a plant-based diet had significant decreases in LDL-C concentration, fasting insulin levels, and body weight.
Most Eligible Adults are Not Receiving Statins for Primary Prevention of ASCVD, Shows New Study
Statin use remained at only 35% among eligible adults since updated guidelines from ACC/AHA on cholesterol treatment.
FDA Grants Breakthrough Therapy Designation for Oral Congenital Adrenal Hyperplasia Medication
Crinecerfont was granted FDA breakthrough therapy designation for the treatment of congenital adrenal hyperplasia.
Daily Dose: Cardiovascular Risk Factors Rising Among Middle-Aged Americans
Coadministration of RSV, Influenza Vaccines Found Safe and Effective in New Study
The coadministration of RSVpreF and seasonal influenza vaccine was found to generate robust immune responses in older adults, reported authors of new study.
Longer Use of ADHD Medications Linked to Higher Risk of CVD in Recent Study
The risk of cardiovascular disease increased with longer cumulative exposure to ADHD medications, peaking at 3 to 5 years of use, reported researchers.
Daily Dose: Lung Cancer Screening Significantly Increases Long-Term Survival Rate
Underestimation of OHE Hospitalizations: Author of New Study Discusses Clinical Implications, Takeaways for Primary Care Clinicians
Arun Jesudian, MD, details key findings from a study he recently presented at The Liver Meeting 2023.
Daily Dose: COVID-19, Opioid Epidemic Primary Drivers of Widening Gender Gap in Life Expectancy
Daily Dose: Lowering SBP to <120 mm Hg Reduces CV Event Risk
Use Weight-First Approach to Educate Patients about Obesity’s Role in HTN
An obesity specialist discusses the importance of using a weight-first approach when educating patients about obesity's role in the development and worsening of hypertension.
